Human melanoma cell line UV responses show independency of p53 function.

UV radiation-induced mutation of the p53 gene is suggested as a causative event in skin cancer, including melanoma. We have analyzed here p53 mutations in melanoma cell lines and studied its stabilization, DNA-binding activity, and target gene activation by UVC. p53 was mutated in three of seven melanoma cell lines. However, high levels of p53 were detected in all cell lines, including melanoma cells with wild-type p53, with the exception of one line with a truncated form. Upon UV induction, p53 accumulated in lines with wild-type p53, and p53 target genes p21Cip1/Waf1, GADD45, and mdm2 were induced, but the induction of p21Cip1/Waf1 was significantly delayed as compared with the increase in p53 DNA-binding activity. However, despite p53 target gene induction, p53 DNA-binding activity was absent in one melanoma line with wild-type p53, and p53 target genes were induced also in cells with mutant p53. In response to UV, DNA replication ceased in all cell lines, and apoptosis ensued in four lines independently of p53 but correlated with high induction of GADD45. The results suggest that in melanoma, several p53 regulatory steps are dislodged; its basal expression is high, its activation in response to UV damage is diminished, and the regulation of its target genes p21Cip1/Waf1 and GADD45 are dissociated from p53 regulation.

[1]  C. Sherr,et al.  Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.

[2]  L. Akslen,et al.  Frequent mutations of the p53 gene in cutaneous melanoma of the nodular type , 1998, International journal of cancer.

[3]  C. Prives,et al.  High mobility group protein-1 (HMG-1) is a unique activator of p53. , 1998, Genes & development.

[4]  M. Laiho,et al.  U.V.C.-Induction of p53 activation and accumulation is dependent on cell cycle and pathways involving protein synthesis and phosphorylation , 1998, Oncogene.

[5]  P. Pollock,et al.  CDKN2A/p16 is inactivated in most melanoma cell lines. , 1997, Cancer research.

[6]  S. H. Kim,et al.  Genetic alterations of p16INK4a and p53 genes in sporadic dysplastic nevus. , 1997, Biochemical and biophysical research communications.

[7]  J. Landers,et al.  Translational enhancement of mdm2 oncogene expression in human tumor cells containing a stabilized wild-type p53 protein. , 1997, Cancer research.

[8]  Raouf Fetni,et al.  A p53-independent pathway for induction of p21waf1cip1 and concomitant G1 arrest in UV-irradiated human skin fibroblasts. , 1997, Cancer research.

[9]  A. Levine,et al.  Differential Regulation of the p21/WAF-1 and mdm2 Genes after High-Dose UV Irradiation: p53-Dependent and p53-Independent Regulation of the mdm2 Gene , 1997, Molecular medicine.

[10]  M. Laiho,et al.  p53 transactivation and protein accumulation are independently regulated by UV light in different phases of the cell cycle , 1997, Molecular and cellular biology.

[11]  Stephen N. Jones,et al.  Regulation of p53 stability by Mdm2 , 1997, Nature.

[12]  M. Oren,et al.  Mdm2 promotes the rapid degradation of p53 , 1997, Nature.

[13]  M. Kripke,et al.  Sunlight and skin cancer: Inhibition of p53 mutations in UV-irradiated mouse skin by sunscreens , 1997, Nature Medicine.

[14]  T. Curran,et al.  Identification of redox/repair protein Ref-1 as a potent activator of p53. , 1997, Genes & development.

[15]  A. Levine.  p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.

[16]  Amanda G Paulovich,et al.  When Checkpoints Fail , 1997, Cell.

[17]  X. Montano,et al.  Analysis of intron 4 of the p53 gene in human cutaneous melanoma. , 1996, Gene.

[18]  A. Hartmann,et al.  Overexpression and mutations of p53 in metastatic malignant melanomas , 1996, International journal of cancer.

[19]  A. Levine,et al.  A functionally inactive p53 protein interatocarcinoma cells is activated by either DNA damage or cellular differentiation , 1996, Nature Medicine.

[20]  C. Prives,et al.  p53: puzzle and paradigm. , 1996, Genes & development.

[21]  D A Scudiero,et al.  An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines. , 1996, Cancer research.

[22]  P. Pollock,et al.  Compilation of somatic mutations of the CDKN2 gene in human cancers: Non‐random distribution of base substitutions , 1996, Genes, chromosomes & cancer.

[23]  Thierry Soussi,et al.  P53 Gene Mutation: Software and Database , 1996, Nucleic Acids Res..

[24]  A. Prescott,et al.  Gadd45 is a nuclear cell cycle regulated protein which interacts with p21Cip1. , 1995, Oncogene.

[25]  D. Lane,et al.  Small peptides activate the latent sequence-specific DNA binding function of p53 , 1995, Cell.

[26]  D. Levin,et al.  Detection of p53 mutations in benign and dysplastic nevi. , 1995, Cancer research.

[27]  M. Laiho,et al.  Cell cycle dependent effects of u.v.-radiation on p53 expression and retinoblastoma protein phosphorylation. , 1995, Oncogene.

[28]  V. A. Flørenes,et al.  Accumulation of p53 protein in human malignant melanoma. Relationship to clinical outcome , 1995, Melanoma research.

[29]  K. Arden,et al.  Mutation and expression of TP53 in malignant melanomas. , 1995, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[30]  C. Cordon-Cardo,et al.  Altered patterns of MDM2 and TP53 expression in human bladder cancer. , 1994, Journal of the National Cancer Institute.

[31]  S. Tornaletti,et al.  Slow repair of pyrimidine dimers at p53 mutation hotspots in skin cancer. , 1994, Science.

[32]  X. Montano,et al.  Analysis of p53 in human cutaneous melanoma cell lines. , 1994, Oncogene.

[33]  N. Hayward,et al.  Mutation and expression of the p53 gene in human malignant melanoma , 1994, Melanoma research.

[34]  A. Levine,et al.  Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. , 1994, Cancer research.

[35]  J. Nesland,et al.  TP53 allele loss, mutations and expression in malignant melanoma. , 1994, British Journal of Cancer.

[36]  D. English,et al.  UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[38]  Xin Lu,et al.  Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? , 1993, Cell.

[39]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[40]  A. Fornace,et al.  Induction of Cellular p53 Activity by DNA-Damaging Agents and Growth Arrest , 1993, Molecular and cellular biology.

[41]  D. Barnes,et al.  p53 immunoreactivity in human malignant melanoma and dysplastic naevi , 1993, The British journal of dermatology.

[42]  N. Lassam,et al.  Overexpression of p53 is a late event in the development of malignant melanoma. , 1993, Cancer research.

[43]  A. Ziegler,et al.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[44]  M. Fritsche,et al.  Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. , 1993, Oncogene.

[45]  D. Lane,et al.  High levels of p53 protein in UV-irradiated normal human skin. , 1993, Oncogene.

[46]  B. Vogelstein,et al.  A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia , 1992, Cell.

[47]  N. Andrews,et al.  A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. , 1991, Nucleic acids research.

[48]  A. Fornace,et al.  DNA damage-inducible transcripts in mammalian cells. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[49]  W. Maltzman,et al.  UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.